Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuji Koike

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Modern Rheumatology|December 16, 2014
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumoniaMichi Tanaka, Ryuji Koike, Ryoko Sakai, et al.
Modern Rheumatology|December 7, 2016
Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategyFumio Hirano, Waka Yokoyama, Hayato Yamazaki, et al.
BMJ Open|March 25, 2025
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (<b>ADVISR</b>) <b>protocol</b>Takanobu Yamamoto, Soichiro Yoshida, Yuya Maezawa, et al.
Modern Rheumatology|December 11, 2013
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and JapanSoo-Kyung Cho, Ryoko Sakai, Toshihiro Nanki, et al.
The Journal of Rheumatology|April 19, 2011
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm SafetyYukiko Komano, Michi Tanaka, Toshihiro Nanki, et al.
Scientific Reports|August 28, 2025
Identification and replication of sex-dimorphic protein quantitative trait loci across multiple ancestries and their associations with diseasesYoungjune Bhak, Vasilis Raptis, Yunye He, et al.
Respiratory Investigation|October 4, 2024
Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severityHiromu Tanaka, Erika Toya, Shotaro Chubachi, et al.
Arthritis Research & Therapy|April 17, 2015
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registryRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Arthritis and Rheumatism|February 28, 2009
Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patientsYukiko Komano, Masayoshi Harigai, Ryuji Koike, et al.
Journal of Gastroenterology|January 25, 2024
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort studyYuta Matsubara, Hiroki Kiyohara, Yohei Mikami, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Modern Rheumatology|December 16, 2014
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumoniaMichi Tanaka, Ryuji Koike, Ryoko Sakai, et al.
Modern Rheumatology|December 7, 2016
Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategyFumio Hirano, Waka Yokoyama, Hayato Yamazaki, et al.
BMJ Open|March 25, 2025
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (<b>ADVISR</b>) <b>protocol</b>Takanobu Yamamoto, Soichiro Yoshida, Yuya Maezawa, et al.
Modern Rheumatology|December 11, 2013
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and JapanSoo-Kyung Cho, Ryoko Sakai, Toshihiro Nanki, et al.
The Journal of Rheumatology|April 19, 2011
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm SafetyYukiko Komano, Michi Tanaka, Toshihiro Nanki, et al.
Scientific Reports|August 28, 2025
Identification and replication of sex-dimorphic protein quantitative trait loci across multiple ancestries and their associations with diseasesYoungjune Bhak, Vasilis Raptis, Yunye He, et al.
Respiratory Investigation|October 4, 2024
Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severityHiromu Tanaka, Erika Toya, Shotaro Chubachi, et al.
Arthritis Research & Therapy|April 17, 2015
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registryRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Arthritis and Rheumatism|February 28, 2009
Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patientsYukiko Komano, Masayoshi Harigai, Ryuji Koike, et al.
Journal of Gastroenterology|January 25, 2024
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort studyYuta Matsubara, Hiroki Kiyohara, Yohei Mikami, et al.
Pageof 11